ACA
NVO

American Capital Advisory’s Novo Nordisk NVO Stock Holding History

American Capital Advisory’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.28K Buy
131
+86
+191% +$3.69K ﹤0.01% 410
2026
Q1 		$1.65K Buy
45
+14
+45% +$663 ﹤0.01% 576
2025
Q4 		$1.58K Sell
31
-12
-28% -$614 ﹤0.01% 506
2025
Q3 		$2.39K Buy
+43
New +$2.52K ﹤0.01% 411

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

American Capital Advisory's NVO Position: Q2 2026 in Review

American Capital Advisory increased its Novo Nordisk (NVO) stake by 191% in Q2 2026, buying an estimated $3.69K and bringing the position to 131 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #410.

American Capital Advisory first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. 873 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • American Capital Advisory held 131 shares of Novo Nordisk worth $6.28K as of Q2 2026.
  • American Capital Advisory bought 86 Novo Nordisk shares in Q2 2026, an estimated $3.69K.
  • Novo Nordisk made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #410 holding.
  • American Capital Advisory first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
  • 873 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.